233 related articles for article (PubMed ID: 12459361)
21. Modeling early haematologic adverse events in conformal and intensity-modulated pelvic radiotherapy in anal cancer.
Robinson M; Sabbagh A; Muirhead R; Durrant L; Van den Heuvel F; Hawkins M
Radiother Oncol; 2015 Nov; 117(2):246-51. PubMed ID: 26409831
[TBL] [Abstract][Full Text] [Related]
22. Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma.
D'Souza WD; Ahamad AA; Iyer RB; Salehpour MR; Jhingran A; Eifel PJ
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1062-70. PubMed ID: 15752885
[TBL] [Abstract][Full Text] [Related]
23. Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
Mell LK; Schomas DA; Salama JK; Devisetty K; Aydogan B; Miller RC; Jani AB; Kindler HL; Mundt AJ; Roeske JC; Chmura SJ
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1431-7. PubMed ID: 17996390
[TBL] [Abstract][Full Text] [Related]
24. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy.
Mell LK; Kochanski JD; Roeske JC; Haslam JJ; Mehta N; Yamada SD; Hurteau JA; Collins YC; Lengyel E; Mundt AJ
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1356-65. PubMed ID: 16757127
[TBL] [Abstract][Full Text] [Related]
25. Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies.
Liang Y; Bydder M; Yashar CM; Rose BS; Cornell M; Hoh CK; Lawson JD; Einck J; Saenz C; Fanta P; Mundt AJ; Bydder GM; Mell LK
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):406-14. PubMed ID: 22687195
[TBL] [Abstract][Full Text] [Related]
26. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
[TBL] [Abstract][Full Text] [Related]
27. Hematologic Nadirs During Chemoradiation for Anal Cancer: Temporal Characterization and Dosimetric Predictors.
Lee AY; Golden DW; Bazan JG; Kopec M; Pelizzari CA; Aggarwal S; Chang DT; Liauw SL
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):306-312. PubMed ID: 28068238
[TBL] [Abstract][Full Text] [Related]
28. Comparison of dosimetric parameters and acute toxicity of intensity-modulated and three-dimensional radiotherapy in patients with cervix carcinoma: A randomized prospective study.
Naik A; Gurjar OP; Gupta KL; Singh K; Nag P; Bhandari V
Cancer Radiother; 2016 Jul; 20(5):370-6. PubMed ID: 27368915
[TBL] [Abstract][Full Text] [Related]
29. Correlation between radiation dose to ¹⁸F-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy.
Rose BS; Liang Y; Lau SK; Jensen LG; Yashar CM; Hoh CK; Mell LK
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1185-91. PubMed ID: 22270171
[TBL] [Abstract][Full Text] [Related]
30. A dosimetric comparison of tomotherapy and volumetric modulated arc therapy in the treatment of high-risk prostate cancer with pelvic nodal radiation therapy.
Pasquier D; Cavillon F; Lacornerie T; Touzeau C; Tresch E; Lartigau E
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):549-54. PubMed ID: 22677369
[TBL] [Abstract][Full Text] [Related]
31. Dose escalation by intensity-modulated radiotherapy boost after whole pelvic radiotherapy in postoperative patients of carcinoma cervix with residual disease.
Khosla D; Patel FD; Rai B; Chakraborty S; Oinam AS; Sharma SC
Clin Oncol (R Coll Radiol); 2013 Jan; 25(1):e1-6. PubMed ID: 22889568
[TBL] [Abstract][Full Text] [Related]
32. Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer.
Peeters ST; Hoogeman MS; Heemsbergen WD; Slot A; Tabak H; Koper PC; Lebesque JV
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1142-52. PubMed ID: 15939547
[TBL] [Abstract][Full Text] [Related]
33. Dosimetric comparison of postoperative whole pelvic radiotherapy for endometrial cancer using three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and helical tomotherapy.
Yang R; Xu S; Jiang W; Wang J; Xie C
Acta Oncol; 2010; 49(2):230-6. PubMed ID: 20001497
[TBL] [Abstract][Full Text] [Related]
34. Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study.
Chan P; Yeo I; Perkins G; Fyles A; Milosevic M
Radiat Oncol; 2006 May; 1():13. PubMed ID: 16722546
[TBL] [Abstract][Full Text] [Related]
35. [A randomized study of intensity-modulated radiation therapy versus three dimensional conformal radiation therapy for pelvic radiation in patients of post-operative treatment with gynecologic malignant tumor].
Ni J; Yin ZM; Yuan SH; Liu NF; Li L; Xu XX; Lou HM
Zhonghua Fu Chan Ke Za Zhi; 2017 Mar; 52(3):168-174. PubMed ID: 28355688
[No Abstract] [Full Text] [Related]
36. [Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer].
Du XX; Yang H; Zhang HJ; Li LA; Fan WS; Meng YG
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):679-686. PubMed ID: 29060966
[No Abstract] [Full Text] [Related]
37. Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies.
Salama JK; Mundt AJ; Roeske J; Mehta N
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1170-6. PubMed ID: 16730136
[TBL] [Abstract][Full Text] [Related]
38. Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size.
Ahamad A; D'Souza W; Salehpour M; Iyer R; Tucker SL; Jhingran A; Eifel PJ
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1117-24. PubMed ID: 15990017
[TBL] [Abstract][Full Text] [Related]
39. Incorporation of SPECT bone marrow imaging into intensity modulated whole-pelvic radiation therapy treatment planning for gynecologic malignancies.
Roeske JC; Lujan A; Reba RC; Penney BC; Diane Yamada S; Mundt AJ
Radiother Oncol; 2005 Oct; 77(1):11-7. PubMed ID: 16024116
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous modulated accelerated radiotherapy in cervical cancer with retroperitoneal lymph node metastasis after radical hysterectomy and pelvic lymphadenectomy.
Li XL; Chen ZY; Cui YC; Sheng XG
Int J Gynecol Cancer; 2015 Jun; 25(5):903-9. PubMed ID: 25822099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
